Cancer Antigen 19-9 (CA 19-9), Human[Cancer Antigen 19-9]

Products_type

Protein
Description

Antigens are peptides or recombinant or native dependent on the production method.
Properties

Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Gene target

Cancer 19-9 19-9 [Cancer 19-9]
Gene symbol

PIRC99, PIRC102, PIRC100, PIRC98, PIRC101
Short name

Cancer Antigen 19-9 (CA 19-9), [Cancer Antigen 19-9]
Technique

antigen, antigenes
Species

Human, Humans
Alternative name

Cancer protein 19-9 (CA 19-9), H. sapiens[Cancer protein 19-9]
Alternative technique

antigenes
Disease

cancer

Name

Blotting, Western
Concept

Scope note: Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
Tree numbers
- E05.196.401.143
- E05.301.300.096
- E05.478.566.320.200
- E05.601.262
- E05.601.470.320.200
Qualifiers

ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data